FlowCardia appoints Barys as COO
This article was originally published in Clinica
Executive Summary
Chris Barys has joined FlowCardia, a developer of endovascular devices for treating chronic total occlusions (CTOs), as chief operating officer. Mr Barys joins the Sunnyvale, California company from Edwards Lifesciences, where he served as vice-president of sales and marketing for the peripheral vascular systems business. In his new role at FlowCardia, he will oversee R&D, quality, clinical and regulatory functions as well as sales and marketing. The company said adoption of its Crosser catheter, designed to recanalise CTOs in the central lumen of the artery, is picking up pace and there is a significant increase in sales activity. Commercialisation of the product began in February 2008